Researchers headed by a team at Pitt University, in collaboration with scientists at Cornell University, have developed a self-destructing, intravenous (i.v.) Bacillus Calmette-Guérin (BCG) vaccine ...
Expert Rev Vaccines. 2013;12(12):1431-1448. There are two trends in TB vaccine development that warrant mentioning. First, there is a new interest in BCG and novel TB vaccines for prevention of ...
PITTSBURGH, Jan. 10, 2025 – A self-destructing vaccine administered intravenously provides additional safety and protection against tuberculosis (TB) in macaque monkeys, suggests new University of ...
Administering the Bacillus Calmette-Guérin (BCG) vaccine during the active phase of COVID-19 may help protect against the development of long COVID. A phase 3 clinical trial initiated in early 2020 ...
A self-destructing vaccine administered intravenously provides additional safety and protection against tuberculosis (TB) in macaque monkeys, suggests new University of Pittsburgh research published ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback